Coagulopathy in Chronic Liver Disease
Pathophysiological Mechanisms
- Chronic hepatitis C leads to impaired synthesis of clotting factors (especially factors II, V, VII, X) in the liver, resulting in prolonged PT and elevated INR despite normal platelet counts 1, 3
- Chronic kidney disease contributes to bleeding risk through uremic platelet dysfunction, even when platelet counts appear normal 4, 5
- The combination of HFpEF and COPD may worsen hepatic congestion and hypoxia, further impairing liver function and coagulation factor synthesis 3, 6
Rebalanced Hemostasis in Liver Disease
- Despite elevated INR and PT, patients with liver disease have a complex "rebalanced hemostasis" where both procoagulant and anticoagulant factors are reduced 2
- This explains why PT/INR correlates poorly with actual bleeding risk in liver disease patients 1
Role of Kidney Disease
- Renal dysfunction is an independent predictor of bleeding in patients with liver disease 4, 5
- Lower glomerular filtration rate is independently associated with delayed bleeding following procedures, even when INR and platelet counts are normal 4
- Acute kidney injury has been associated with increased bleeding risk after procedures in patients with decompensated cirrhosis 3
Diagnostic Considerations
- Viscoelastic tests (thromboelastography/thromboelastometry) provide a more comprehensive assessment of coagulation than PT/INR alone 7
Management Implications
- Correction of prolonged INR with fresh frozen plasma (FFP) is not recommended to decrease procedure-related bleeding risk in patients with cirrhosis 2
- FFP transfusion in patients with cirrhosis and prolonged INR frequently does not lead to full normalization of prothrombin time 2
- Blood products should be used sparingly as they increase portal pressure and carry risks of transfusion-related complications 3, 8
- For procedures requiring improved hemostasis, thrombopoietin receptor agonists may be considered for severe thrombocytopenia, though this doesn't apply to this patient with normal platelets 3, 8